AGC Biologics is the product of the convergence and integration of Asahi Glass Company (AGC) Bioscience, CMC Biologics, BIOMEVA GmbH and Molecular Medicine S.p.A. (“MolMed”). Our global network spans three continents, with cGMP-compliant facilities in Seattle, WA; Boulder, CO; Copenhagen, Denmark; Heidelberg, Germany; Chiba, Japan, and Milan, Italy. Today, our staff of more than 1,600 dedicated employees is committed to providing solutions for more than 100 customers on three continents.
In keeping with our focus on providing innovative solutions to complex challenges, AGC Biologics is also committed to ecological stewardship and support of the communities in which we operate. We are ISO 14001 certified to ensure that we have processes in place to measure and improve our impact on the environment. We also provide training opportunities for university students and military service members in our local communities who are seeking to develop scientific and technical skills.